Treatment Duration and Results : While both Zepbound and Semaglutide are GLP-1 medications, their mechanisms differ
An analysis of insurance claims for GLP-1 weight-loss therapy (in patients without diabetes) found only 29% were still on the medication at 1 year, and a mere 15% at 2 years (source)
References Badenhorst, T., Svirskis, D., Wilsher, T., & O'Sullivan, J
As a small family business, we take great pride in delivering beautifully crafted, long-lasting street furniture that stands up to the harshest weather conditions and everyday wear and tear
Injection Site Reactions: Risk of infections, swelling, and pain at the injection site due to improper administration
How does Yunique Medical approach GLP-1 therapy differently